Literature DB >> 2505018

Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women.

P Vague1, I Juhan-Vague, V Chabert, M C Alessi, C Atlan.   

Abstract

Epidemiologic data strongly suggest that upper distribution of body fat and high plasminogen activator inhibitor (PAI) activity are risk factors for cardiovascular disease. Therefore, a link between these two parameters was evaluated by studying 51 menstrually active nondiabetic obese women. In this group positive correlations were observed between body mass index (BMI), waist to hip circumference ratio (W/H ratio, which estimates body fat distribution), plasma insulin, and PAI activity. In addition, plasma triglycerides were related to the W/H ratio and insulin and PAI activity. Partial correlations revealed that BMI was independently and solely related to W/H ratio, which was also independently related to plasma insulin, which in turn related to PAI activity. These results suggest that upper body fat distribution acts as a risk factor of cardiovascular disease through its association with high PAI activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505018     DOI: 10.1016/0026-0495(89)90241-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  18 in total

1.  Elevated expression of transforming growth factor-beta in adipose tissue from obese mice.

Authors:  F Samad; K Yamamoto; M Pandey; D J Loskutoff
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  Prothrombotic markers in asymptomatic dyslipidemic subjects.

Authors:  David Karasek; Helena Vaverkova; Milan Halenka; Dagmar Jackuliakova; Zdenek Frysak; Ludek Slavik; Dalibor Novotny
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

3.  Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus.

Authors:  Omar Bayomy; Ajay D Rao; Rajesh Garg; Anand Vaidya; Alyssa R Kotin; Beata Reiber; Stephanie Nijmeijer; Marcelo F Di Carli; Michael Jerosch-Herold; Raymond Y Kwong; Gail K Adler
Journal:  Metab Syndr Relat Disord       Date:  2017-05-15       Impact factor: 1.894

4.  Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.

Authors: 
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

5.  Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1.

Authors:  F Samad; K T Uysal; S M Wiesbrock; M Pandey; G S Hotamisligil; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

6.  Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice.

Authors:  F Samad; D J Loskutoff
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

7.  Plasma fibrinogen as cardiovascular risk factor.

Authors:  L Breimer
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

Review 8.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

9.  In young post-myocardial infarction male patients elevated plasminogen activator inhibitor-1 correlates with insulin resistance and endothelial dysfunction.

Authors:  Barbara Eržen; Mišo Šabovič
Journal:  Heart Vessels       Date:  2012-09-22       Impact factor: 2.037

10.  Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.

Authors:  F Samad; K Yamamoto; D J Loskutoff
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.